Tags

Type your tag names separated by a space and hit enter

Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab. 2011 Oct; 96(10):2968-79.JC

Abstract

OBJECTIVE

The aim was to formulate practice guidelines for determining settings where patients are most likely to benefit from the use of continuous glucose monitoring (CGM).

PARTICIPANTS

The Endocrine Society appointed a Task Force of experts, a methodologist, and a medical writer.

EVIDENCE

This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence.

CONSENSUS PROCESS

One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, the Diabetes Technology Society, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines.

CONCLUSIONS

The Task Force evaluated three potential uses of CGM: 1) real-time CGM in adult hospital settings; 2) real-time CGM in children and adolescent outpatients; and 3) real-time CGM in adult outpatients. The Task Force used the best available data to develop evidence-based recommendations about where CGM can be beneficial in maintaining target levels of glycemia and limiting the risk of hypoglycemia. Both strength of recommendations and quality of evidence were accounted for in the guidelines.

Authors+Show Affiliations

Mills-Peninsula Health Services, San Mateo, California 94401, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

21976745

Citation

Klonoff, David C., et al. "Continuous Glucose Monitoring: an Endocrine Society Clinical Practice Guideline." The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 10, 2011, pp. 2968-79.
Klonoff DC, Buckingham B, Christiansen JS, et al. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(10):2968-79.
Klonoff, D. C., Buckingham, B., Christiansen, J. S., Montori, V. M., Tamborlane, W. V., Vigersky, R. A., & Wolpert, H. (2011). Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 96(10), 2968-79. https://doi.org/10.1210/jc.2010-2756
Klonoff DC, et al. Continuous Glucose Monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(10):2968-79. PubMed PMID: 21976745.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. AU - Klonoff,David C, AU - Buckingham,Bruce, AU - Christiansen,Jens S, AU - Montori,Victor M, AU - Tamborlane,William V, AU - Vigersky,Robert A, AU - Wolpert,Howard, AU - ,, PY - 2011/10/7/entrez PY - 2011/10/7/pubmed PY - 2011/12/13/medline SP - 2968 EP - 79 JF - The Journal of clinical endocrinology and metabolism JO - J Clin Endocrinol Metab VL - 96 IS - 10 N2 - OBJECTIVE: The aim was to formulate practice guidelines for determining settings where patients are most likely to benefit from the use of continuous glucose monitoring (CGM). PARTICIPANTS: The Endocrine Society appointed a Task Force of experts, a methodologist, and a medical writer. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, the Diabetes Technology Society, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: The Task Force evaluated three potential uses of CGM: 1) real-time CGM in adult hospital settings; 2) real-time CGM in children and adolescent outpatients; and 3) real-time CGM in adult outpatients. The Task Force used the best available data to develop evidence-based recommendations about where CGM can be beneficial in maintaining target levels of glycemia and limiting the risk of hypoglycemia. Both strength of recommendations and quality of evidence were accounted for in the guidelines. SN - 1945-7197 UR - https://www.unboundmedicine.com/medline/citation/21976745/Continuous_glucose_monitoring:_an_Endocrine_Society_Clinical_Practice_Guideline_ L2 - https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2010-2756 DB - PRIME DP - Unbound Medicine ER -